Downstream of AKT1 includes MMP-7 and MMP-9, as well as OATP1B1 and OATP1B3, therefore METTL3-regulated NIFK-AS1 promotes HCC progression and Sorenifib resistance (Chen et al., 2021c). The gene discussed is AKT1; the disease is hepatocellular carcinoma.